Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Natural Calculus Bovis (NCB), also known as Niu Huang, is a traditional Chinese medicine derived from the natural gallstones of *Bos taurus domesticus Gmelin*. It has been utilized for over two millennia in traditional medicine for its heat-clearing, detoxifying, and neuroprotective properties. NCB is a complex natural product containing several bioactive components, including bilirubin, bile acids (such as cholic acid and deoxycholic acid), and taurine. These constituents are believed to exert anti-inflammatory, antioxidant, and neuroprotective effects, which are particularly relevant in the management of secondary brain injury following hypertensive intracerebral hemorrhage. Tongji Hospital is currently evaluating NCB in an investigator-initiated clinical trial to assess its efficacy and safety compared to Calculus Bovis Sativus (CBS), a biochemically synthesized substitute, in patients with acute intracerebral hemorrhage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Natural Calculus Bovis.